Beyond Air, Inc. Exchange Rate Effect on Cash
Beyond Air, Inc. (XAIR) reported Exchange Rate Effect on Cash of -$21.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-13
- Beyond Air, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2026-06-30 was -$21.00K, a 116.54% decline year-over-year.
- Beyond Air, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2025-06-30 was $127.00K, a 14.41% increase year-over-year.
- Beyond Air, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2024-06-30 was $111.00K, a 177.50% increase year-over-year.
- Beyond Air, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2023-06-30 was $40.00K, a 76.74% decline year-over-year.
- Beyond Air, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2026 was $194.00K.
- Beyond Air, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2025 was -$45.00K.
- Beyond Air, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2024 was -$77.00K.
- Beyond Air, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2023 was -$43.00K, a 144.79% decline from fiscal 2022.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$21.00K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $194.00K 10-K · filed 2026-06-26 | |||
| 2025-12-31 | $170.00K 10-Q · filed 2026-02-13 | |||
| 2025-09-30 | $145.00K 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | $127.00K 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | -$45.00K 10-K · filed 2026-06-26 | |||
| 2024-12-31 | $16.00K 10-Q · filed 2026-02-13 | |||
| 2024-09-30 | -$23.00K 10-Q · filed 2025-11-10 | |||
| 2024-06-30 | $111.00K 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | -$77.00K 10-K · filed 2025-06-20 | |||
| 2023-12-31 | $18.00K 10-Q · filed 2025-02-10 | |||
| 2023-09-30 | -$19.00K 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $40.00K 10-Q · filed 2024-08-06 | |||
| 2023-03-31 | -$43.00K 10-K · filed 2024-06-24 | |||
| 2022-12-31 | $63.00K 10-Q · filed 2024-02-12 | |||
| 2022-09-30 | $2.00K 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | $172.00K 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | $96.00K 10-K · filed 2023-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |